News & Stories

When to Consider a Brain Tumor Clinical Trial A common misconception is that brain tumor clinical trials are only an option after multiple recurrences or as a last resort. In reality, there are five critical time points of eligibility, or windows of opportunity, when patients can consider brain tumor clinical trials — sometimes even before surgery or starting treatment. Because eligibility often depends […] May 19, 2025

Biomarker Testing Gave Julia Answers and the Confidence to Grow Her Family At 26, Julia was a new mom and five months postpartum when her world stopped: she had a brain tumor. After surgery, her health care team believed it was aggressive cancer. But thanks to biomarker testing, Julia’s path — and her prognosis — changed entirely.  The Initial Diagnosis In 2019, Julia started experiencing strange, unsettling […] May 9, 2025

Let’s Talk About Oligodendroglioma While oligodendroglioma is a relatively rare brain tumor, accounting for 1.2% of all primary brain tumors, an estimated 14,950 Americans are living with this tumor and navigating the unique challenges of this disease.  Let’s talk about what makes oligodendrogliomas different from other brain tumors and the difficulties people living with this tumor type and their […] March 28, 2025

How Biomarker Testing Changed Everything for a Patient With Brainstem Glioma When Ben S-L. misjudged a corner and walked straight into a wall at work, he realized something wasn’t right. This incident, combined with his increasing headaches and a numb tongue, led Ben to see a neurologist and demand an MRI. Two weeks before turning 32, doctors diagnosed Ben with an inoperable high-grade brainstem glioma. Ben […] March 4, 2025

Unlocking Better Outcomes: Melissa’s Advocacy for Biomarker Testing and Brain Cancer Research Last month, Melissa F. and her partner Jess E. arrived bright and early to help set up for the Race for Hope Greater Philadelphia, an event that has become deeply personal to them both. For Melissa, it’s a way to give back to the community that has supported them since Jess’s brain tumor recurrence in […] November 8, 2024